CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 2 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $495 | -50.5% | 4,479 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 4,479 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -50.0% | 4,479 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | -33.3% | 4,479 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | -40.0% | 4,479 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $5,000 | -37.5% | 4,479 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $8,000 | -11.1% | 4,479 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $9,000 | -25.0% | 4,479 | -55.1% | 0.01% | -30.0% |
| Q4 2020 | $12,000 | -33.3% | 9,980 | 0.0% | 0.01% | -37.5% |
| Q3 2020 | $18,000 | -78.6% | 9,980 | 0.0% | 0.02% | -82.6% |
| Q2 2020 | $84,000 | +61.5% | 9,980 | 0.0% | 0.09% | +46.0% |
| Q1 2020 | $52,000 | – | 9,980 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |